Neurotech International |
High $0.04 |
Low $0.04 |
Trades 37 |
Turnover $81,892 |
Volume 2,106,389 |
| 30 June 2023 at 3:45pm | ||||
|
Market Cap (13-Nov) $32,321,400 (1,318th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 2,106,389 |
Shortsold (23-Jan) 143,231 (0.01%) (538th) |
|
52w High $0.021 |
52w Low $0.010 |
P/E - |
EPS -0.01 |
Investor Presentation
NTI released this announcement to the ASX on 20 March 2023, 9:57. The announcement is not marked as price sensitive, and is 24 page(s) in length and 2.47MB in size.
You can view all announcements from NTI and see how they appear on a price chart on the announcements page.
At the date of this announcement, NTI was 0.014% short sold according to ASIC data. It was ranked the 584th most shorted stock on the ASX. It is now ranked as the 538th most shorted stock on the ASX with 0.011% of total shares short sold as of the latest reported data (23 January 2026).
| Other Recent Announcements from NTI | |
|---|---|
| Notification of cessation of securities - NTI | 30 June 2023, 17:06 |
| Notification regarding unquoted securities - NTI | 28 June 2023, 16:14 |
| NTI to Present at Rett Syndrome Foundation Meeting | 5 June 2023, 8:27 |
| Investor Presentation | 20 March 2023, 9:57 |
| NTI to Launch Phase II Clinical Trial in Rett Syndrome | 20 March 2023, 9:03 |
| Investor Conference Call - 52 Week Autism Study Results | 17 March 2023, 10:01 |
| Investor Presentation | 17 March 2023, 9:53 |
If you were already registered, log in here.